NCT06699160View on ClinicalTrials.gov

Refobacin Revision-3 Bone Cement Post-Market Study

Not yet recruitingOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Revision Arthroplasty
Interventions
DEVICE

Revision arthroplasty

Hip or knee revision surgery resulting from aseptic loosening of the prosthesis and/or infection of the prosthesis by gentamicin and/or clindamycin sensitive strains.

Trial Locations (1)

3582

Diakonessenhuis UMC Utrecht, Utrecht

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY